GLP-1 therapies created a consumer-driven market for pharmaceuticals that pairs digital access, partnerships, and retention ...

FDA’s final SIUU guidance loosens some off-label communication rules, but drugmakers still face strict compliance demands to ...

With AI, the tools are ready and the budgets are allocated, but they are flowing to the wrong places, write Romi Singh, Ph.D.

The commercial leader/board dynamic will matter even more as pricing pressures and policy complexity increase, writes Beren Therapeutics Bennett Smith.

I was a medical student in Belgrade when a friend noticed an unusual object in the corner of my apartment. It was an American football, something I had carried back with me from years of living in ...

Speed alone no longer guarantees success; here’s what matters most in today’s launch environment. In today’s launch environment, order of entry (OOE) isn’t destiny. Many brands still anchor strategy ...

Then: Back in 2020, former Life Science Leader chief editor Rob Wright spoke with biopharma veteran Rob Perez about founding Life Science Cares, an industry philanthropic organization and platform for ...

In biotech, partnerships are often viewed as milestones - announcements that validate a technology or provide funding for the next stage of development. For platform companies, however, collaborations ...

For many families living with rare pediatric diseases, hope often arrives quietly — after years of uncertainty, missed diagnoses, and being told that treatment may never come in time. For Lindsey ...

Each January, the J.P. Morgan Healthcare Conference helps to set the biopharmaceutical industry agenda for the coming year, and more suits can be seen on the streets of San Francisco than during any ...

Marc Tessier-Lavigne, Ph.D. (left) and Martin Makary, M.D. (right) The FDA must “cut the idle time” that exists within the agency to bring drugs to market faster, said Commissioner Martin Makary, M.D.

During a July episode of the Business of Biotech, Ebrahim Delpassand, M.D., founder, chairman, and CEO at RadioMedix, pointed out the importance of knowing, as a company, what you do best. It won’t be ...